SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia

BACKGROUND: SARS-CoV-2 antibody testing is required for estimating population seroprevalence and vaccine response studies. It may also increase case identification when used as an adjunct to routine molecular testing. We performed a validation study and evaluated the use of automated high-throughput...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Virol
Auteurs principaux: Sekirov, Inna, Barakauskas, Vilte E., Simons, Janet, Cook, Darrel, Bates, Brandon, Burns, Laura, Masud, Shazia, Charles, Marthe, McLennan, Meghan, Mak, Annie, Chahil, Navdeep, Vijh, Rohit, Hayden, Althea, Goldfarb, David, Levett, Paul N, Krajden, Mel, Morshed, Muhammad
Format: Artigo
Langue:Inglês
Publié: The Authors. Published by Elsevier B.V. 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282439/
https://ncbi.nlm.nih.gov/pubmed/34304088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2021.104914
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires